Overall survival stratified by progression status at week 8
| Sequence | Progression by Week 8? | Progression by Week 8? (R vs NR-NP) | |||
|---|---|---|---|---|---|
| No | Yes | R | NR-NP | P | |
| N (%), Median OS (days) (95% CI) | N (%), Median OS (days) (95% CI) | N (%), Median OS (days) (95% CI) | N (%), Median OS (days) (95% CI) | N (%), Median OS (days) (95% CI) | |
| 2D | 67 (91%) | 7 (9%) | 18 (24%) | 49 (66%) | 7 (9%) |
| 303 (232–400) | 110 (74–192) | 364 (280–510) | 268 (217–378) | 110 (74–192) | |
| P < .0001a (n = 74) | P = .35: R vs NR-NP | ||||
| dT1 | 67 (91%) | 7 (9%) | 28 (38%) | 39 (53%) | 7 (9%) |
| 303 (232–400) | 110 (74–192) | 425.5 (311–660) | 223 (180–276) | 110 (74–192) | |
| P < .0001a (n = 74) | P = .01a: R vs NR-NP | ||||
Note:—N indicates number of patients; R, responder; NR-NP, non-responder/non-progressor; P, progression.
↵a Significant.